Brief: India's Sun Pharma Advanced Research Co Posts March-Qtr Profit
May 8 (Reuters) - Sun Pharma Advanced Research Company Ltd
SPRC.NS :
* MARCH QUARTER PROFIT 24.8 MILLION RUPEES VERSUS LOSS
318.9
MILLION RUPEES YEAR AGO
* MARCH QUARTER REVENUE FROM OPERATIONS 200.9 MILLION RUPEES
VERSUS 416 MILLION RUPEES YEAR AGO
* QTRLY EXCEPTIONAL ITEM WAS 489.8 MILLION RUPEES
Source text - http://bit.ly/2rrEuYI
Further company coverage: SPRC.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sun Pharma Advanced Research
See all newsAdvisory: Alert incorrectly tagged to Sun Pharma Advanced Research withdrawn
Brief: Sun Pharma Advanced Research Appoints Anil Raghavan As MD And CEO Effective August 11
Brief: Sun Pharma Advanced Research Says Ocuvex Therapeutics Gets Complete Response Letter For PDP-716 NDA
India's Sun Pharma Advanced Research jumps after swinging to Q4 profit
Brief: Sun Pharma Advanced Research March-Quarter Consol Profit 17.61 Billion Rupees